{"nct_id":"NCT02625961","title":"Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2016-02-10","start_date_type":"ACTUAL","primary_completion_date":"2025-10-31","primary_completion_date_type":"ESTIMATED","completion_date":"2025-10-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}